Swollen Joint Count (44 Joints)

$ 30.50

4.9 (166) In stock

Unraveling heterogeneity within ACPA-negative rheumatoid arthritis

Comparison of the efficacy and risk of discontinuation between non

PDF) Outcome of patients with seronegative spondyloarthritis

Assessment of short-term symptomatic efficacy of tocilizumab in

PDF) The number of risk factors for persistent disease determines

Swollen Joint Count (44 Joints)

Joint Counts and Rheumatoid Arthritis

PDF) Outcome of patients with seronegative spondyloarthritis

PDF) Rheumatoid arthritis presenting with mono- or oligo-arthritis